SMS Lifesciences India Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in SMS Lifesciences India Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
68.85% Gain from 52W Low
30.2
TTM PE Ratio
Below industry Median
26.5
Price to Book Ratio
Low in industry
1.2
Dividend yield 1yr %
Low in industry
0.2
TTM PEG Ratio
PEG TTM is negative
-1.2
RSI
RSI is mid-range
63.3
MFI
MFI strongly Overbought
84.4

SMS Lifesciences India Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

SMS Lifesciences India Ltd shareholding Pattern

Promoter
71.2%
Public
28.8%
Promoter
70.7%
Public
29.3%
Promoter
70.3%
Public
29.7%
Promoter
70.3%
Public
29.7%
Promoter
70.3%
Public
29.7%
Promoter
70.3%
Public
29.7%
Foreign Institutions
0.1%

SMS Lifesciences India Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5Day EMA
799.70
10Day EMA
785.70
12Day EMA
780.10
20Day EMA
760.00
26Day EMA
747.80
50Day EMA
713.20
100Day EMA
668.00
200Day EMA
624.80
5Day SMA
803.80
10Day SMA
777.90
20Day SMA
755.90
30Day SMA
721.10
50Day SMA
706.50
100Day SMA
653.40
150Day SMA
616.00
200Day SMA
590.50
Delivery & Volume
Resistance & Support
807.88
Pivot
Resistance
First Resistance
815.67
Second Resistance
823.73
Third Resistance
831.52
Support
First Support
799.82
Second support
792.03
Third Support
783.97
Relative Strength Index
63.34
Money Flow Index
84.44
MACD
32.26
MACD Signal
28.81
Average True Range
40.37
Average Directional Index
26.83
Rate of Change (21)
23.77
Rate of Change (125)
57.38
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Brooks Laboratories Ltd.
230.18
71.29
185.15
Lactose (India) Ltd.
-
-
-
Coral Laboratories Ltd.
-
-
-
Kimia Biosciences Ltd.
-
-
-
Gennex Laboratories Ltd.
-
-
-
Par Drugs & Chemicals Ltd.
-
-
-

SMS Lifesciences India Ltd Company background

Founded in: 2006
Managing director: T V V S N Murthy
The Company was incorporated originally as Potluri Real Estate Private Limited on 31May, 2006 for undertaking the activities of real estate business and the Company could not commence business activities andthe companys name has been changed to Potluri Packaging Industries Private Limited on 6 November, 2013. The Company could not undertake any such activities, once again the companys name has been changed to SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company has become a wholly owned subsidiary company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016. Subsequently converted into a Public Company under the Companies Act, 2013 w.e.f. 22 June, 2016.The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad.The Demerger Scheme sanctioned by the National Company Law Tribunal (NCLT) vide its order dated 1505 2017 received by the Company on 17052017 has been implemented with appointed date as 01st April, 2016 as provided in the Scheme. Accordingly, the Semi Regulated Facilities i.e., Unit I, IV and V along with (i) premises situated at Industrial Estate, Sanath Nagar, Hyderabad (ii) Industrial Development area, Jeedimetla, Hyderabad (iii) Flat No. 417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad and (iv) Vacant Land admeasuring Ac 19.00 situated at Pharma City, Parawada, Vishakapatnam. Along with these assets the company has conferred with the liabilities mentioned in the books of the demerged company as on the appointed date. The Company allotted 30,23,287 equity shares of Rs.10 each to the shareholders of SMS Pharmaceuticals Limited (transferor Company) on 27 June, 2017 in pursuance of demerger scheme.Pursuant to the scheme of arrangement, the equity shares of the Company were listed in the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) w.e.f 17 August 2017.During the FY2018,the Board approved the acquisition of Mahi Drugs Private Limited (Mahi Drugs), a Bulk Drugs manufacturing Company located at Vishakhapatnam, Andhra Pradesh, as a wholly owned (100%) subsidiary of SMS Lifesciences India Limited by entering into a share purchase agreement.During the FY2019, the Company had achieved production of 2040 M.T of APIs and their Intermediaries in comparison with 1729 M.T for the FY 201718. During the year 201819, Mahi Drugs Private Limited became wholly owned subsidiary of the Company with effect from 17 September, 2018.During the year 201920, producation has declined from 1,364 M.T. of APIs and their intermediates in comparison with 2,040 M.T. for the previous year due to the new USFDA guidelines on Ranitidine HCLThe Company has received the prestigious India Pharma Bulk Drugs Company of the year award on 5 March, 2020 at the 5th edition of India Pharma and Medical Device 2020 conference organized by FICCI in collaboration with Ministry of Chemical and fertilizers, Govt. of India.
Read More

SMS Lifesciences India Ltd FAQs

The past 1-year return of SMS Lifesciences India Ltd [SMSLIFE] share was 48.73. The SMS Lifesciences India Ltd [SMSLIFE] share hit a 1-year low of Rs. 464.05 and a 1-year high of Rs. 948.1.

You can easily buy SMS Lifesciences India Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage